Biora Therapeutics, Inc.

Kevin Howe

Mitchell Lawrence Jones

Christopher Loren Wahl

Sharat Singh

Mark Sasha Drlik

Nathan John Muller

Nelson Quintana

Iman Niknia

Tuyen Nguyen

Jeffrey A Shimizu

Edward Mudge

Nicholas Mark Salt

Nia Eleri Stevens

Stuart Robert Abercrombie

Christopher Ian Bunce

Pejman Rahimian

Arana Perera

Harry Stylli

Ryan Elliott Jones

This disclosure features methods and compositions for treating inflammatory disorders or conditions that arise in a tissue originating from the endoderm using an immune modulator.

Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a JAK or other kinase inhibitor.

Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor

Ingestible devices can directly deliver therapeutic agents to desired tissue(s) of the GI tract of a subject, such as the submucosa, the mucosa, and/or the mucus layer of the GI tract, and methods of using the same. The ingestible devices can deliver therapeutic agents in a safe, effective, and reliable manner. The disclosure also provides pharmaceutical compositions for use in methods of treating a disease or condition in a subject in need thereof.

Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Growing community of inventors

London, United Kingdom

Kevin Howe